South & Central America GMP Cell Therapy Consumables Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)

Code: BMIRE00027852 | Pages: 150 | Industry: Biotechnology | Date: Jan 2023 | Type: Regional

The South & Central America GMP cell therapy consumables market is expected to grow from US$ 584.43 million in 2022 to US$ 2,579.39 million by 2028; it is estimated to grow at a CAGR of 28.0% from 2022 to 2028.

 

Increasing Clinical Trials and Rising GMP Demand is Fueling the South & Central America GMP Cell Therapy Consumables Market

Cell therapies are constantly evolving, improving, and providing new treatment options for various disorders, such as cancer, autoimmune disorders, and neurological disorders. Immunotherapy is a new approach for cancer treatment. Cell therapies are currently being evaluated in clinical trials for various cancer types, separately and combined with other treatments. Additionally, the cellular immunotherapy targets that are being evaluated in clinical trials, new immunotherapy approaches are also being developed constantly, which is investigated through clinical trials. Since 2017, FDA approved about six chimeric antigen receptor (CAR) T-cell therapies for the treatment of blood cancer, including lymphomas, some leukemia forms, and multiple myeloma. More than 500 CAR-T and 17 chimeric antigen receptor natural killer (CAR-NK) cell trials are currently being conducted across the world, including the four CAR-T cell products—Yescarta, Tecartus, Kymriah, and Breyanzi that are already available in the market. Further, the CAR cellular therapies field is newly developed, and preclinical and clinical studies have already shown remarkable results. It is believed that CAR-based cellular therapies are profoundly promising and will lead the development of approved personalized therapeutic options in the coming years. With new therapeutic modalities emerging in the cell and gene space (CAR-T), companies are required to develop, evaluate, and test these therapies in clinical trials, along with maintaining patient safety. These emerging therapies require a scientific standard of controls and GMPs to ensure patient safety. Thus, it is important to ensure that the equipment used during these processes is compatible with GMP manufacturing environments for cell therapies, and all clinical consumables are manufactured under conditions that fulfil GMP requirements appropriate for the phase and scale of manufacturing. Therefore, the increasing clinical trials among various fields will fuel the South & Central America GMP cell therapy consumables market.

 

South & Central America GMP Cell Therapy Consumables Market Overview

 

The South & Central America GMP cell therapy consumables market includes Brazil, Argentina, and the Rest of South & Central America. The region held the smallest portion of the market in the global analysis. The market for cell therapy consumables in the region is expected to have growth opportunities during the forecast period. The GMP cell therapy consumables market in the SAM region is expected to grow owing to factors such as, establishment of pharmaceutical companies in the region, increasing awareness, and rising healthcare expenditure by the countries, the high adoption rate of cell therapy and increased in medical tourism are likely to create demand for GMP cell therapy consumables during the forecast period. Furthermore, increase in research activities and increased use of advanced medicinal products are likely to amplify the market growth.

 

South & Central America GMP Cell Therapy Consumables Market Revenue and Forecast to 2028 (US$ Million)

South & Central America GMP Cell Therapy Consumables Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

South & Central America GMP Cell Therapy Consumables Market Segmentation

 

The South & Central America GMP cell therapy consumables market is segmented on the basis of product, cell therapy, process, end use, and country.

 

Based on product, the South & Central America GMP cell therapy consumables market is segmented into kits, reagents/molecular biology reagents, growth factors/cytokines and interleukins (including protein and nucleic acid purification buffers), and others. The kits segment held the largest share of the market in 2022.

 

Based on cell therapy, the South & Central America GMP cell therapy consumables market is segmented into NK cell therapy, stem cell therapy, T-cell therapy, and others. The T-cell therapy segment registered the largest share of the market in 2022.

 

Based on process, the South & Central America GMP cell therapy consumables market is segmented into cell collection and characterization/sorting and separation, cell culture and expansion/preparation, cryopreservation, cell processing and formulation, cell isolation and activation, cell distribution/handling, process monitoring and control/readministration/quality assurance, and others. The cell collection and characterization/sorting and separation segment held the largest share of the market in 2022.

 

Based on end use, the South & Central America GMP cell therapy consumables market is segmented into clinical, commercial, and research. The clinical segment held the largest share of the market in 2022.

 

Based on country, the South & Central America GMP cell therapy consumables market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America dominated the market in 2022.

 

Bio-Techne Corp, BPS Bioscience Inc, Corning Inc, FUJIFILM Irvine Scientific Inc, Global Life Sciences Solutions USA LLC, Lonza Group AG, Merck KGaA, Miltenyi Biotec BV & Co KG, Sartorius AG, and Thermo Fisher Scientific Inc are the leading companies operating in the South & Central America GMP cell therapy consumables market.

1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South & Central America GMP Cell Therapy Consumables Market – by Product

1.3.2        South & Central America GMP Cell Therapy Consumables Market – by Cell Therapy

1.3.3        South & Central America GMP Cell Therapy Consumables Market – by End Use

1.3.4        South & Central America GMP Cell Therapy Consumables Market – by End Use

1.3.5        South & Central America GMP Cell Therapy Consumables Market – by Country

2.           South & Central America GMP Cell Therapy Consumables Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South & Central America GMP Cell Therapy Consumables Market – Market Landscape

4.1         Overview

4.2         South & Central America PEST Analysis

4.3         Experts’ Opinion

5.           South & Central America GMP Cell Therapy Consumables Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rise in Research & Development and Drug Discovery

5.1.2        Increase in Strategic Collaborations

5.2         Market Restraints

5.2.1        Stringent Regulatory Policies

5.3         Market Opportunities

5.3.1        Growing Regulatory Approvals for Cell and Gene Therapy (CGT) Product

5.4         Future Trends

5.4.1        Increasing Clinical Trials and Rising GMP Demand

5.5         Impact Analysis

6.           GMP Cell Therapy Consumables Market – South & Central America Analysis

6.1         South & Central America GMP Cell Therapy Consumables Market Revenue Forecast and Analysis

7.           South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – by Product

7.1         Overview

7.2         South & Central America GMP Cell Therapy Consumables Market Revenue Share, by Product 2021 & 2028 (%)

7.3         Kits

7.3.1        Overview

7.3.2        Kits: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Reagents/ Molecular Biology Reagents

7.4.1        Overview

7.4.2        Reagents/ Molecular Biology Reagents: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers)

7.5.1        Overview

7.5.2        Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers): South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Others

7.6.1        Overview

7.6.2        Others: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

8.           South & Central America GMP Cell Therapy Consumables Market Analysis and Forecasts to 2028 – by Cell Therapy

8.1         Overview

8.2         South & Central America GMP Cell Therapy Consumables Market, by Cell Therapy 2021 & 2028 (%)

8.3         NK Cell Therapy

8.3.1        Overview

8.3.2        NK Cell Therapy: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Stem Cell Therapy

8.4.1        Overview

8.4.2        Stem Cell Therapy: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

8.5         T-cell Therapy

8.5.1        Overview

8.5.2        T-cell Therapy: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

9.           South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – by End Use

9.1         Overview

9.2         South & Central America GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)

9.3         Clinical

9.3.1        Overview

9.3.2        Clinical: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Commercial

9.4.1        Overview

9.4.2        Commercial: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Research

9.5.1        Overview

9.5.2        Research: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

10.        South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – by Process

10.1      Overview

10.2      South & Central America GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)

10.3      Cell Collection and Characterization/Sorting and Separation

10.3.1     Overview

10.3.2     Cell Collection and Characterization/ Sorting and Separation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Cell Culture and Expansion/Preparation

10.4.1     Overview

10.4.2     Cell Culture and Expansion/Preparation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Cryopreservation

10.5.1     Overview

10.5.2     Cryopreservation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

10.6      Cell Processing and Formulation

10.6.1     Overview

10.6.2     Cell Processing and Formulation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

10.7      Cell Isolation and Activation

10.7.1     Overview

10.7.2     Cell Isolation and Activation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

10.8      Cell Distribution/Handling

10.8.1     Overview

10.8.2     Cell Distribution/Handling: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

10.9      Process Monitoring and Control/Readministration/Quality Assurance

10.9.1     Overview

10.9.2     Process Monitoring and Control/Readministration/Quality Assurance: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

10.10   Other

10.10.1  Overview

10.10.2  Other: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

11.        South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – Country Analysis

11.1      Overview

11.1.1     South & Central America: GMP Cell Therapy Consumables Market, by Country, 2021 & 2028 (%)

11.1.1.1       Brazil: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.1.1       Overview

11.1.1.1.2       Brazil: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.1.3       Brazil: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ ‘Million)

11.1.1.1.4       Brazil: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ ‘Million)

11.1.1.1.5       Brazil: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ ‘Million)

11.1.1.1.6       Brazil: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ ‘Million)

11.1.1.2       Argentina: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.2.1       Overview

11.1.1.2.2       Argentina: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.2.3       Argentina: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ ‘Million)

11.1.1.2.4       Argentina: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ ‘Million)

11.1.1.2.5       Argentina: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ ‘Million)

11.1.1.2.6       Argentina: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ ‘Million)

11.1.1.3       Rest of South & Central America: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.3.1       Overview

11.1.1.3.2       Rest of South & Central America: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)

11.1.1.3.3       Rest of South & Central America: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ ‘Million)

11.1.1.3.4       Rest of South & Central America: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ ‘Million)

11.1.1.3.5       Rest of South & Central America: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ ‘Million)

11.1.1.3.6       Rest of South & Central America: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ ‘Million)

12.        GMP Cell Therapy Consumables Market – Industry Landscape

12.1      Overview

12.2      Growth Strategies in GMP Cell Therapy Consumables Market

12.3      Inorganic Growth Strategies

12.3.1     Overview

12.4      Organic Growth Strategies

12.4.1     Overview

13.        Company Profiles

13.1      Sartorius AG

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Thermo Fisher Scientific Inc

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Miltenyi Biotec BV & Co KG

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Bio-Techne Corp

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Corning Inc

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      FUJIFILM Irvine Scientific Inc

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Lonza Group AG

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      BPS Bioscience Inc

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Merck KGaA

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Global Life Sciences Solutions USA LLC

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             Brazil: GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2.             Brazil: GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ ‘Million)

Table 3.             Brazil: GMP Cell Therapy Consumables Market, by End Use– Revenue and Forecast to 2028 (US$ ‘Million)

Table 4.             Brazil: GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5.             Argentina: GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6.             Argentina: GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7.             Argentina: GMP Cell Therapy Consumables Market, by End Use– Revenue and Forecast to 2028 (US$ ‘Million)

Table 8.             Argentina: GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9.             Rest of South & Central America: GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 10.          Rest of South & Central America: GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ ‘Million)

Table 11.          Rest of South & Central America: GMP Cell Therapy Consumables Market, by End Use– Revenue and Forecast to 2028 (US$ ‘Million)

Table 12.          Rest of South & Central America: GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ ‘Million)

Table 13.          Recent Inorganic Growth Strategies in the GMP Cell Therapy Consumables Market

Table 14.          Recent Organic Growth Strategies in GMP Cell Therapy Consumables Market

Table 15.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           South & Central America GMP Cell Therapy Consumables Market Segmentation

Figure 2.           South & Central America GMP Cell Therapy Consumables Market, by Country

Figure 3.           South & Central America GMP Cell Therapy Consumables Market Overview

Figure 4.           Kits Segment Held the Largest Share of Product Segment in South & Central America GMP Cell Therapy Consumables Market

Figure 5.           Argentina is Expected to Show Remarkable Growth During Forecast Period

Figure 6.           South & Central America: PEST Analysis

Figure 7.           Experts’ Opinion

Figure 8.           South & Central America GMP Cell Therapy Consumables Market: Impact Analysis of Drivers and Restraints

Figure 9.           South & Central America GMP Cell Therapy Consumables Market – Revenue Forecast and Analysis – 2019–2028

Figure 10.        South & Central America GMP Cell Therapy Consumables Market Revenue Share, by Product 2021 & 2028 (%)

Figure 11.        Kits: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Reagents/ Molecular Biology Reagents: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers): South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Others: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        South & Central America GMP Cell Therapy Consumables Market, by Cell Therapy 2021 & 2028 (%)

Figure 16.        NK Cell Therapy: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Stem Cell Therapy: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        T-cell Therapy: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Other Applications: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        South & Central America GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)

Figure 21.        Clinical: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Commercial: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Research: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        South & Central America GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)

Figure 25.        Cell Collection and Characterization/Sorting and Separation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Cell Culture and Expansion/Preparation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Cryopreservation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Cell Processing and Formulation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Cell Isolation and Activation: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Cell Distribution/Handling: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Process Monitoring and Control/Readministration/Quality Assurance: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Other: South & Central America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        South & Central America: GMP Cell Therapy Consumables Market, by Key Country – Revenue (2021) (US$ ‘Million)

Figure 34.        South & Central America: GMP Cell Therapy Consumables Market, by Country, 2021 & 2028 (%)

Figure 35.        Brazil: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 36.        Argentina: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 37.        Rest of South & Central America: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 38.        Growth Strategies in GMP Cell Therapy Consumables Market

  1. Bio-Techne Corp
  2. BPS Bioscience Inc
  3. Corning Inc
  4. FUJIFILM Irvine Scientific Inc
  5. Global Life Sciences Solutions USA LLC
  6. Lonza Group AG
  7. Merck KGaA
  8. Miltenyi Biotec BV & Co KG
  9. Sartorius AG
  10. Thermo Fisher Scientific Inc
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000